Vor Biopharma
Clinical trials sponsored by Vor Biopharma, explained in plain language.
-
New drug telitacicept aims to tame Sjögren's in major trial
Disease control Recruiting nowThis Phase 3 study tests whether telitacicept, a biologic drug given as a shot, can reduce disease activity in adults with active primary Sjögren's disease. About 250 participants will receive either telitacicept or a placebo for 48 weeks. The main goal is to see if the drug impr…
Phase: PHASE3 • Sponsor: Vor Biopharma • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New hope for muscle weakness: drug trial targets myasthenia gravis
Disease control Recruiting nowThis study tests a drug called telitacicept in 180 adults with generalized myasthenia gravis, a condition causing muscle weakness. Participants receive either the drug or a placebo for 24 weeks to see if it improves daily activities and muscle strength. The goal is to control the…
Phase: PHASE3 • Sponsor: Vor Biopharma • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC